M. I. Mas-Fuster

Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats

R. Nalda-Molina, A. Ramón-López, P. Más-Serrano, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Suitability of the AUC Ratio as an Indicator of the Pharmacokinetic Advantage in HIPEC.

R. Nalda-Molina, A. Ramón-López, P. Más-Serrano, 2018, Journal of pharmaceutical sciences.

Impact of Laparotomy and Intraperitoneal Hyperthermic Instillation (LIHI) on the oxaliplatin pharmacokinetics after intravenous administration in Wistar rats

R. Nalda-Molina, A. Ramón-López, P. Más-Serrano, 2017, Cancer Chemotherapy and Pharmacology.

Importance of standardizing the dose in hyperthermic intraperitoneal chemotherapy (HIPEC): a pharmacodynamic point of view

R. Nalda-Molina, A. Ramón-López, M. I. Mas-Fuster, 2013, Cancer Chemotherapy and Pharmacology.